November 07, 2019
WELLESLEY, Mass., Nov. 7, 2019– The cryostat microtomes market is driven by growing incidences of cancer, continuous technological advancements in diagnostic techniques and growing demand for outpatient surgery centers around the world. Technological advancements in diagnostic techniques and growing demand for outpatient surgery centers around the world, according to a report by BCC Research, “Global Cryostat Microtome Equipment: A BCC Research Overview.”
The market expects to see a compound annual growth rate (CAGR) of 6.9% through 2024, when it could be worth $60.6 million.
Read the full report here: https://www.bccresearch.com/market-research/biotechnology/cryostat-microtome-equipment-market-report.html
“Ease-of-use and better consistency of section quality are increasing the popularity of automatic cryostat microtomes in the medical world,” writes BCC analysts. “However, demand for manual cryostat microtomes remains strong primarily due to their much lower cost of procurement and ability to offer an extra measure of control during sectioning.”
U.S. Cryostat Microtome Market Research Expands Due to Growing Health Threats
The U.S. cryostat microtome market for applications in the research sector is predicted to see significant growth in the coming years. Between 2013 and 2017, medical and health research and development investment grew by 27%. In the coming years, investments in medical and health-related research activities are expected to continue to increase due to the growing incidences of deadly and debilitating health threats in the country.
Editors/reporters requesting analyst interviews should contact Sarah Greenberg at firstname.lastname@example.org.
Global Cryostat Microtome Equipment Market( BIO190A )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.